Gilead Sciences
(NQ:
GILD
)
79.17
+0.45 (+0.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Gilead Churns Out Additional Trodelvy Data
September 16, 2021
Gilead Sciences Inc (NASDAQ: GILD) announced new data from the Phase 3 ASCENT study of Trodelvy (sacituzumab govitecan-hziy) in relapsed or refractory metastatic...
Via
Benzinga
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused...
Via
Benzinga
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
August 31, 2021
Which subset of the COVID-19 healthcare market will outperform over the next year?
Via
The Motley Fool
Exposures
COVID-19
A Look Into Gilead Sciences Debt
August 31, 2021
Shares of Gilead Sciences (NASDAQ:GILD) rose by 7.09% in the past three months. Before we understand the importance of debt, let us look at how much debt Gilead Sciences...
Via
Benzinga
Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks
August 31, 2021
After 22 years at the helm of Galapagos NV (NASDAQ: GLPG), chief executive Onno van de Stolpe has decided it is time to retire and hand the reins to new...
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Analyzing Gilead Sciences's Unusual Options Activity
August 11, 2021
On Wednesday, shares of Gilead Sciences (NASDAQ:GILD) saw...
Via
Benzinga
Analyzing Gilead Sciences's Unusual Options Activity
August 06, 2021
Gilead Sciences (NASDAQ:GILD) shares experienced unusual o...
Via
Benzinga
Could Moderna Take Down Gilead Sciences?
August 30, 2021
It's too early for a "yes" answer. But it's too premature for a "no" response as well.
Via
The Motley Fool
Gilead Wins Reversal of $1.2B Patent Loss to Bristol-Myers: Bloomberg
August 26, 2021
Gilead Sciences Inc (NASDAQ: GILD) persuaded a U.S. appeals court to reverse a $1.2 billion judgment Bristol-Myers Squibb & Co (NYSE: BMY) had won over immuno-...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Siemens' Fatty Liver Disease Blood Test Wins FDA De Novo Clearance
August 24, 2021
The FDA has granted clearance to a blood test from Siemens Healthineers (OTC: SMMNY) to provide an easier and potentially more accurate diagnostic alternative than an invasive...
Via
Benzinga
Exposures
Product Safety
Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks?
August 23, 2021
If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...
Via
Talk Markets
Exposures
Product Safety
Why Fate Therapeutics Stock Is Sliding Today
August 20, 2021
The positive results the company announced after the bell yesterday didn't meet some lofty expectations.
Via
The Motley Fool
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Why NRx Pharmaceuticals Stock Jumped 11.8% Today
August 18, 2021
The company provided a positive update from a clinical study evaluating its COVID-19 therapy Zyesami.
Via
The Motley Fool
Exposures
COVID-19
China's Red Ribbon School Provides a Refuge for Children Living With HIV
August 18, 2021
China's Red Ribbon School Provides a Refuge for Children Living With HIV
Via
News Direct
Topics
Bonds
Product Recall
Exposures
Debt Markets
Legal
Product Safety
Wall Street Journal Creates A Pitch In Favor Of Royalty Pharma
August 17, 2021
Drug development, both a lucrative and a risky segment. Royalty Pharma plc (NASDAQ: RPRX) offers a middle ground for its investors. The Company was founded in 1996 and...
Via
Benzinga
Large Cap Biopharma Stocks provide Growth and Value
August 16, 2021
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
What To Know About Rand Paul Failing To Disclose Gilead Stock Purchase For 16 Months
August 12, 2021
Stock transactions by members of the U.S. Congress and their spouses have been a hot topic over the last several years. A transaction disclosed late Wednesday is drawing heavy...
Via
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
August 11, 2021
Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
Via
News Direct
Exposures
COVID-19
Stocks That Hit 52-Week Highs On Monday
August 16, 2021
Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs. Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to set a new 52-week...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 09, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Fake Versions Of Gilead's HIV Drugs Are In Circulation In US
August 06, 2021
Gilead Sciences Inc (NASDAQ: GILD) warned Thursday that its original HIV treatments Biktarvy and Descovy had been replaced by fake versions at some pharmacies....
Via
Benzinga
3 Biotech Stocks That Could Make You Richer in August (and Beyond)
August 05, 2021
All three have blockbuster products already on the market.
Via
The Motley Fool
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money
August 04, 2021
An effective oral antiviral therapy for the coronavirus may be around the corner.
Via
The Motley Fool
Exposures
COVID-19
International AIDS Society Leaders on the Future of HIV Prevention and Treatment
August 03, 2021
International AIDS Society Leaders on the Future of HIV Prevention and Treatment
Via
News Direct
Exposures
COVID-19
Why Investors Should Like BioNTech's Latest Deal With Gilead
July 31, 2021
There are several pluses for BioNTech in the deal.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.